Patents Examined by Ellly-Gerald Stoica
  • Patent number: 9724395
    Abstract: The present invention provides compositions and methods for treating cancer or a metastasis thereof in a subject. In some embodiments, the methods involve administering a composition comprising therapeutically effective amount of at least one immune stimulator to the subject. In some embodiments, a combination of at least two immune stimulators is used for the treatment. In some embodiments, the combination includes an alpha thymosin peptide and an additional immune stimulator, and/or optionally one or more additional anti-cancer agents.
    Type: Grant
    Filed: October 21, 2015
    Date of Patent: August 8, 2017
    Assignee: SciClone Pharmaceuticals, Inc.
    Inventors: Robert S. King, Cynthia W. Tuthill, Friedhelm Blobel